PregLem gains $26M
|
VENTURE CAPITAL |
|||
|
COMPANY |
AMOUNT/ROUND |
LEAD INVESTORS |
DESCRIPTION |
|
PregLem
|
$26M
|
Sofinnova Partners |
PregLem has programs for gynecological conditions and infertility. |
|
Kiadis Pharma
|
$20.16M
|
Alta Partners |
Kiadis is developing therapies for bone marrow transplants and the treatment of aggressive cancers. |